Product Information

LEVETIRACETAM 750 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1105 per EA under NDC 31722053812. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Oct 8, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LEVETIRACETAM 750 MG TABLET

Levetiracetam
$0.1105per EA

Strength

750 mg/1

NDC

31722053812

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LEVETIRACETAM

Approval Type

Generic (ANDA)

FDA Application

ANDA090515

FDA Approved

10/8/2010

TE Code

AB

On Market Since

10/8/2010

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for LEVETIRACETAM 750 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 53.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1105 per EA
All-time high$0.3075 (Sep 10, 2014)
All-time low$0.0954 (Nov 20, 2024)
52-week high$0.1191
52-week low$0.1105
Median price$0.1644
Average price$0.1661
Largest weekly change+37.8% (Aug 20, 2014)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-2.4%

1M

-2.4%

3M

-5.2%

6M

-3.2%

1Y

-7.2%

3Y

-24.5%

5Y

-36.4%

All

-53.6%

Generic Alternatives

The matcher finds 20 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LEVETIRACETAM 750 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 750 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.1105 per EA (NDC 31722053812), effective Aug 19, 2026.

How has the price of LEVETIRACETAM 750 MG TABLET changed over time?

Over the history we have for it, the NADAC for LEVETIRACETAM 750 MG TABLET has declined 53.6%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 750 MG TABLET?

Since Nov 28, 2013, the NADAC for LEVETIRACETAM 750 MG TABLET has ranged from a low of $0.0954 (Nov 20, 2024) to a high of $0.3075 (Sep 10, 2014), with a median of $0.1644 per EA.

Are there cheaper alternatives to LEVETIRACETAM 750 MG TABLET?

Yes. 20 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVETIRACETAM 750 MG TABLET, is $0.1056 per EA — about 4% below LEVETIRACETAM 750 MG TABLET.

Who manufactures LEVETIRACETAM 750 MG TABLET?

LEVETIRACETAM 750 MG TABLET (NDC 31722053812) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.